Digital and Pharma 4.0

Latest content

AdobeStock_1873267675

Building the foundation for the orchestrated lab of the future

2026-07-13T07:00:00+01:00Sponsored by

As pharmaceutical laboratories face mounting pressure to accelerate timelines and manage growing data complexity, intelligent laboratory operations underpin the next generation of connected, autonomous lab environments.

Join now

Unlock exclusive industry insights

  • Bookmark articles and resources to access anytime
  • Enjoy free access to industry leading resources, webinars and insights
  • Stay informed with the latest news and breakthroughs in drug discovery
  • Receive updates and recommendations tailored to your research interests
Become a member

CCT LogiPharma

Thermal assurance as an operating model: why the pharmaceutical cold chain must evolve beyond visibility

2026-05-28T07:30:00+01:00Sponsored by

Real-time monitoring has become standard practice in temperature-controlled distribution. The differentiator now is whether organisations can convert signals into decisions early enough to prevent excursions, reduce waste and strengthen resilience. As Vijay Paliwal, Vice President, Global Advanced Solutions & Customer Experience at Cold Chain Technologies explains, that shift is driving a new operating model for cold chain management: thermal assurance.

gavel legal AI technology concept

Adopting an AI-driven approach to scale with confidence

2026-05-14T11:03:00+01:00

Exploring how mid-size pharma can meet European regulatory expectations without rebuilding infrastructure.

trade show concept

CPHI Americas 2026 returns to Philadelphia with AI, regulatory focus

2026-04-30T10:47:00+01:00Sponsored by

The annual conference for contract pharmaceutical manufacturing partners returns to Pennsylvania, centering on regulatory shifts, AI and biotech innovation.

Surface-Enhanced Raman Spectroscopy (SERS): sample on substrate inside the cuvette that enhances Raman scattering signals

Process Raman spectroscopy: closing biomanufacturing’s measurement infrastructure gap

2026-04-28T10:59:00+01:00

The biopharmaceutical industry has embraced Pharma 4.0 concepts, but the measurement infrastructure required to realise autonomous facilities and continuous bioprocessing remains underdeveloped. Process Raman spectroscopy offers continuous, non-destructive monitoring at frequencies aligned with cell culture dynamics, bridging the gap between control system capabilities and available data.